Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Interleukin-1 | 29 | 2004 | 1248 | 1.200 |
Why?
|
Babesiosis | 7 | 2022 | 92 | 1.200 |
Why?
|
Clofazimine | 1 | 2022 | 41 | 0.780 |
Why?
|
Wound Infection | 2 | 2023 | 246 | 0.760 |
Why?
|
Adjuvants, Immunologic | 6 | 2018 | 1036 | 0.680 |
Why?
|
Lasers | 4 | 2018 | 952 | 0.660 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 698 | 0.590 |
Why?
|
Anti-Infective Agents | 3 | 2023 | 983 | 0.550 |
Why?
|
Vaccines | 4 | 2018 | 844 | 0.540 |
Why?
|
Staphylococcal Infections | 4 | 2023 | 1407 | 0.520 |
Why?
|
Complement Activation | 11 | 1996 | 445 | 0.520 |
Why?
|
Tumor Necrosis Factor-alpha | 24 | 1997 | 4352 | 0.460 |
Why?
|
Photosensitizing Agents | 5 | 2023 | 623 | 0.460 |
Why?
|
Dendritic Cells | 5 | 2018 | 2747 | 0.450 |
Why?
|
HSP70 Heat-Shock Proteins | 4 | 2018 | 397 | 0.420 |
Why?
|
Glucocorticoids | 1 | 2021 | 2161 | 0.390 |
Why?
|
Guillain-Barre Syndrome | 1 | 2013 | 127 | 0.390 |
Why?
|
Skin | 4 | 2018 | 4484 | 0.360 |
Why?
|
Glutathione | 1 | 2013 | 583 | 0.350 |
Why?
|
Herpes Simplex | 1 | 2013 | 478 | 0.340 |
Why?
|
Injections, Intradermal | 3 | 2018 | 116 | 0.330 |
Why?
|
Potassium Iodide | 2 | 2018 | 14 | 0.320 |
Why?
|
Tetracyclines | 2 | 2018 | 64 | 0.310 |
Why?
|
Burns | 8 | 2013 | 1882 | 0.310 |
Why?
|
Erythrocytes | 5 | 2013 | 2413 | 0.300 |
Why?
|
Herpesvirus 1, Human | 1 | 2013 | 753 | 0.290 |
Why?
|
Heterocyclic Compounds | 2 | 2019 | 246 | 0.290 |
Why?
|
Complement C3a | 5 | 2004 | 66 | 0.280 |
Why?
|
Endotoxins | 8 | 1994 | 520 | 0.270 |
Why?
|
Complement Pathway, Alternative | 6 | 1987 | 113 | 0.270 |
Why?
|
Infrared Rays | 3 | 2018 | 247 | 0.270 |
Why?
|
Complement C5a | 10 | 2004 | 100 | 0.240 |
Why?
|
Anaphylatoxins | 1 | 2004 | 21 | 0.240 |
Why?
|
GPI-Linked Proteins | 2 | 2018 | 470 | 0.230 |
Why?
|
Influenza Vaccines | 3 | 2017 | 768 | 0.230 |
Why?
|
Vaccination | 4 | 2018 | 3384 | 0.230 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3206 | 0.230 |
Why?
|
Cancer Vaccines | 3 | 2018 | 1051 | 0.220 |
Why?
|
Vitamin K 3 | 1 | 2023 | 14 | 0.220 |
Why?
|
Anti-Bacterial Agents | 5 | 2023 | 7406 | 0.200 |
Why?
|
Staphylococcus epidermidis | 4 | 1997 | 123 | 0.200 |
Why?
|
Monocytes | 3 | 2004 | 2570 | 0.190 |
Why?
|
Lipopolysaccharides | 13 | 1998 | 2206 | 0.190 |
Why?
|
Microbial Sensitivity Tests | 3 | 2023 | 1936 | 0.190 |
Why?
|
Biofilms | 2 | 2023 | 627 | 0.190 |
Why?
|
Methylene Blue | 2 | 2018 | 155 | 0.180 |
Why?
|
Mast Cells | 2 | 2018 | 1392 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 9 | 1998 | 1844 | 0.180 |
Why?
|
Babesia | 2 | 1998 | 29 | 0.170 |
Why?
|
Mesothelioma | 2 | 2018 | 807 | 0.170 |
Why?
|
Complement C5 | 4 | 1988 | 103 | 0.170 |
Why?
|
Reactive Oxygen Species | 3 | 2023 | 2139 | 0.170 |
Why?
|
Light | 3 | 2020 | 1353 | 0.170 |
Why?
|
Uropathogenic Escherichia coli | 1 | 2018 | 6 | 0.160 |
Why?
|
Photochemotherapy | 3 | 2018 | 823 | 0.150 |
Why?
|
Otitis Media | 1 | 2020 | 286 | 0.150 |
Why?
|
Cystitis, Interstitial | 1 | 1997 | 66 | 0.140 |
Why?
|
Lasers, Semiconductor | 1 | 2017 | 41 | 0.140 |
Why?
|
Recombinant Proteins | 11 | 2014 | 6534 | 0.140 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 454 | 0.140 |
Why?
|
Neisseria gonorrhoeae | 1 | 2019 | 239 | 0.140 |
Why?
|
Lung | 6 | 2013 | 10002 | 0.140 |
Why?
|
Urticaria | 1 | 1997 | 150 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 883 | 0.130 |
Why?
|
Platelet Activation | 2 | 1997 | 645 | 0.130 |
Why?
|
Cellulose | 1 | 1996 | 118 | 0.130 |
Why?
|
Mastocytosis | 1 | 1997 | 150 | 0.120 |
Why?
|
Acute-Phase Reaction | 1 | 1995 | 91 | 0.120 |
Why?
|
Babesia microti | 2 | 2006 | 31 | 0.120 |
Why?
|
Gonorrhea | 1 | 2019 | 346 | 0.120 |
Why?
|
Antibodies, Viral | 3 | 2020 | 3156 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2822 | 0.120 |
Why?
|
Sialoglycoproteins | 6 | 2004 | 315 | 0.120 |
Why?
|
Drug Synergism | 7 | 2018 | 1757 | 0.120 |
Why?
|
Platelet Activating Factor | 1 | 1994 | 143 | 0.120 |
Why?
|
Avidin | 1 | 2014 | 43 | 0.110 |
Why?
|
Communicable Diseases, Emerging | 2 | 2014 | 148 | 0.110 |
Why?
|
Membranes, Artificial | 1 | 1996 | 366 | 0.110 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 727 | 0.110 |
Why?
|
Immunomodulation | 1 | 2018 | 549 | 0.110 |
Why?
|
Cells, Cultured | 12 | 2018 | 18966 | 0.110 |
Why?
|
Lentivirus | 1 | 2016 | 508 | 0.110 |
Why?
|
Receptors, AMPA | 1 | 2015 | 336 | 0.110 |
Why?
|
Rabbits | 14 | 1994 | 4772 | 0.110 |
Why?
|
Organophosphorus Compounds | 1 | 1994 | 206 | 0.110 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1375 | 0.110 |
Why?
|
Shock, Septic | 5 | 1995 | 768 | 0.110 |
Why?
|
Ibuprofen | 3 | 1989 | 229 | 0.110 |
Why?
|
Lassa Fever | 1 | 2014 | 97 | 0.100 |
Why?
|
Interleukin-2 | 3 | 1995 | 1889 | 0.100 |
Why?
|
Erythrocyte Count | 1 | 2013 | 157 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
Humans | 69 | 2023 | 761596 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 3 | 2018 | 3733 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1154 | 0.100 |
Why?
|
Sepsis | 4 | 1994 | 2585 | 0.100 |
Why?
|
Complement System Proteins | 4 | 1991 | 735 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1213 | 0.100 |
Why?
|
Urinary Tract Infections | 1 | 2018 | 802 | 0.100 |
Why?
|
Laser Therapy | 1 | 2018 | 1092 | 0.100 |
Why?
|
Encephalitis | 1 | 2015 | 440 | 0.090 |
Why?
|
Urinary Bladder | 1 | 1997 | 1152 | 0.090 |
Why?
|
Orthomyxoviridae Infections | 1 | 2013 | 254 | 0.090 |
Why?
|
Radioimmunoassay | 9 | 1993 | 861 | 0.090 |
Why?
|
Pregnadienes | 2 | 1983 | 24 | 0.090 |
Why?
|
Bacterial Proteins | 2 | 2014 | 3847 | 0.090 |
Why?
|
Danazol | 2 | 1983 | 45 | 0.090 |
Why?
|
Wounds and Injuries | 3 | 1995 | 2492 | 0.090 |
Why?
|
Influenza A virus | 1 | 2013 | 458 | 0.090 |
Why?
|
Animals | 42 | 2019 | 168475 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2302 | 0.080 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 1995 | 621 | 0.080 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4878 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Autoantibodies | 2 | 2015 | 2118 | 0.080 |
Why?
|
Blood Coagulation | 1 | 1995 | 1154 | 0.080 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 6 | 2004 | 299 | 0.080 |
Why?
|
Escherichia coli | 6 | 2018 | 4217 | 0.080 |
Why?
|
Blood Platelets | 2 | 1997 | 2479 | 0.080 |
Why?
|
Gene Expression | 3 | 2004 | 7581 | 0.080 |
Why?
|
Viral Vaccines | 1 | 2014 | 596 | 0.080 |
Why?
|
Angioedema | 6 | 1994 | 184 | 0.070 |
Why?
|
Female | 38 | 2020 | 392705 | 0.070 |
Why?
|
Benzylamines | 2 | 2019 | 247 | 0.070 |
Why?
|
Biocompatible Materials | 1 | 1996 | 1685 | 0.070 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2007 | 59 | 0.070 |
Why?
|
Cell Movement | 3 | 2018 | 5205 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2016 | 3396 | 0.070 |
Why?
|
Hypotension | 2 | 1993 | 879 | 0.070 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 964 | 0.070 |
Why?
|
Thiazoles | 1 | 1994 | 1517 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 1993 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3617 | 0.070 |
Why?
|
Oxygen | 2 | 2019 | 4227 | 0.070 |
Why?
|
Hemodynamics | 7 | 1995 | 4160 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2016 | 1813 | 0.070 |
Why?
|
Dental Implants | 2 | 1992 | 795 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3878 | 0.060 |
Why?
|
Receptor, Anaphylatoxin C5a | 2 | 2004 | 87 | 0.060 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1526 | 0.060 |
Why?
|
Bacillus | 1 | 2005 | 78 | 0.060 |
Why?
|
Drug Approval | 1 | 2012 | 814 | 0.060 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2005 | 95 | 0.060 |
Why?
|
Mice | 18 | 2019 | 81539 | 0.060 |
Why?
|
Telepathology | 1 | 2005 | 77 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8633 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3810 | 0.060 |
Why?
|
Mycobacterium smegmatis | 1 | 2005 | 126 | 0.060 |
Why?
|
Fever | 4 | 2007 | 1618 | 0.060 |
Why?
|
Mice, Inbred C57BL | 9 | 2018 | 22174 | 0.060 |
Why?
|
Drug Discovery | 1 | 2012 | 1051 | 0.060 |
Why?
|
Pertussis Toxin | 1 | 2004 | 176 | 0.060 |
Why?
|
Cytokines | 3 | 1995 | 7396 | 0.060 |
Why?
|
Neutrophils | 5 | 1994 | 3767 | 0.060 |
Why?
|
Pyridines | 1 | 1996 | 2875 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2014 | 3162 | 0.060 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 285 | 0.050 |
Why?
|
Antiprotozoal Agents | 2 | 2008 | 94 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2004 | 659 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3335 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2005 | 499 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11461 | 0.050 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2005 | 384 | 0.050 |
Why?
|
Complement C1 Inactivator Proteins | 3 | 1994 | 89 | 0.050 |
Why?
|
Blood Pressure | 5 | 1993 | 8481 | 0.050 |
Why?
|
Bacteroides fragilis | 2 | 1985 | 252 | 0.050 |
Why?
|
Mice, Inbred BALB C | 4 | 2018 | 6214 | 0.050 |
Why?
|
Cytosol | 1 | 2004 | 888 | 0.050 |
Why?
|
Male | 25 | 2020 | 360846 | 0.040 |
Why?
|
Complement C4 | 5 | 1983 | 217 | 0.040 |
Why?
|
Middle Aged | 13 | 2020 | 220921 | 0.040 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.040 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 16 | 0.040 |
Why?
|
Adult | 20 | 2020 | 221210 | 0.040 |
Why?
|
Chromatography, Affinity | 1 | 2020 | 532 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2020 | 397 | 0.040 |
Why?
|
Shock | 3 | 1991 | 314 | 0.040 |
Why?
|
DNA Primers | 2 | 2010 | 2820 | 0.040 |
Why?
|
Singlet Oxygen | 1 | 2018 | 58 | 0.040 |
Why?
|
Immunity, Innate | 3 | 2020 | 3066 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2020 | 1060 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4544 | 0.040 |
Why?
|
Biotechnology | 1 | 2020 | 282 | 0.040 |
Why?
|
Arachnid Vectors | 1 | 1998 | 24 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 1992 | 364 | 0.040 |
Why?
|
Mice, Inbred DBA | 3 | 2006 | 621 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2192 | 0.040 |
Why?
|
Cell Adhesion | 3 | 1998 | 3088 | 0.040 |
Why?
|
Cell Line | 2 | 2020 | 15601 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 1994 | 10194 | 0.040 |
Why?
|
RNA, Messenger | 5 | 1998 | 12794 | 0.040 |
Why?
|
Ticks | 1 | 1998 | 70 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58984 | 0.040 |
Why?
|
Wound Healing | 1 | 1989 | 2805 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14665 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 59260 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 96 | 0.040 |
Why?
|
Immunoassay | 1 | 2020 | 745 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 2 | 1995 | 807 | 0.030 |
Why?
|
Cell Degranulation | 1 | 1997 | 277 | 0.030 |
Why?
|
Fibroblasts | 1 | 1987 | 4142 | 0.030 |
Why?
|
Complement C4a | 1 | 1996 | 14 | 0.030 |
Why?
|
Receptors, CCR2 | 1 | 2017 | 215 | 0.030 |
Why?
|
Rats | 5 | 2018 | 23741 | 0.030 |
Why?
|
Alkylation | 1 | 1996 | 84 | 0.030 |
Why?
|
Cricetulus | 1 | 2018 | 814 | 0.030 |
Why?
|
Ixodes | 1 | 1996 | 40 | 0.030 |
Why?
|
Leukocyte Count | 4 | 1994 | 1596 | 0.030 |
Why?
|
Arthroscopy | 1 | 2022 | 969 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23447 | 0.030 |
Why?
|
Adsorption | 1 | 1996 | 197 | 0.030 |
Why?
|
Indomethacin | 1 | 1996 | 325 | 0.030 |
Why?
|
Candidiasis | 1 | 1978 | 365 | 0.030 |
Why?
|
Insect Vectors | 1 | 1996 | 136 | 0.030 |
Why?
|
Binding Sites | 1 | 2004 | 6056 | 0.030 |
Why?
|
CHO Cells | 1 | 2018 | 1387 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2018 | 730 | 0.030 |
Why?
|
Up-Regulation | 1 | 2004 | 4125 | 0.030 |
Why?
|
Pyrogens | 1 | 1994 | 17 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 587 | 0.030 |
Why?
|
Edetic Acid | 1 | 1995 | 276 | 0.030 |
Why?
|
Complement C3 | 3 | 1991 | 435 | 0.030 |
Why?
|
Blood Bactericidal Activity | 2 | 1987 | 124 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2019 | 3677 | 0.030 |
Why?
|
Ribosomes | 1 | 2018 | 501 | 0.030 |
Why?
|
Cats | 1 | 1996 | 975 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2018 | 518 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1995 | 400 | 0.030 |
Why?
|
HLA-DR3 Antigen | 1 | 2014 | 24 | 0.030 |
Why?
|
Thrombin | 1 | 1997 | 591 | 0.030 |
Why?
|
Cricetinae | 1 | 2018 | 2423 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1227 | 0.030 |
Why?
|
Tyrosine | 1 | 2018 | 1440 | 0.030 |
Why?
|
C-Reactive Protein | 4 | 1991 | 3826 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 585 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 10766 | 0.030 |
Why?
|
Vagina | 1 | 2019 | 838 | 0.030 |
Why?
|
Platelet Count | 2 | 1994 | 781 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6075 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 726 | 0.030 |
Why?
|
Syphilis | 1 | 1976 | 243 | 0.030 |
Why?
|
Bacteroides Infections | 2 | 1985 | 89 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9542 | 0.030 |
Why?
|
Computational Biology | 1 | 2005 | 3517 | 0.030 |
Why?
|
Interleukin-8 | 2 | 1993 | 696 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4576 | 0.030 |
Why?
|
Hepatitis | 1 | 1995 | 228 | 0.030 |
Why?
|
Lassa virus | 1 | 2014 | 99 | 0.030 |
Why?
|
Penicillins | 1 | 1976 | 402 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2005 | 2020 | 0.030 |
Why?
|
Russia | 1 | 2014 | 384 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1606 | 0.030 |
Why?
|
Granuloma | 1 | 1995 | 328 | 0.030 |
Why?
|
Surface Properties | 1 | 1996 | 1161 | 0.030 |
Why?
|
Serum Albumin | 1 | 1996 | 672 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18255 | 0.030 |
Why?
|
Multiple Organ Failure | 1 | 1995 | 387 | 0.030 |
Why?
|
Adolescent | 6 | 2018 | 88326 | 0.030 |
Why?
|
Macrophage Activation | 1 | 1995 | 553 | 0.020 |
Why?
|
Base Sequence | 2 | 2010 | 12441 | 0.020 |
Why?
|
Ovalbumin | 1 | 2014 | 677 | 0.020 |
Why?
|
Aged | 10 | 2020 | 169310 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16990 | 0.020 |
Why?
|
Pulmonary Surfactants | 2 | 1989 | 162 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 1994 | 409 | 0.020 |
Why?
|
Leishmaniasis, Visceral | 1 | 1992 | 99 | 0.020 |
Why?
|
Hemorrhage | 2 | 1995 | 3424 | 0.020 |
Why?
|
Cell Separation | 1 | 1997 | 1720 | 0.020 |
Why?
|
Dogs | 1 | 1996 | 3839 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6345 | 0.020 |
Why?
|
Calcium | 1 | 2004 | 5722 | 0.020 |
Why?
|
Choline | 2 | 1989 | 515 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1048 | 0.020 |
Why?
|
Cattle | 1 | 1996 | 3849 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3076 | 0.020 |
Why?
|
Occupational Health | 1 | 2016 | 806 | 0.020 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 1989 | 41 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8656 | 0.020 |
Why?
|
Protein Engineering | 1 | 2014 | 549 | 0.020 |
Why?
|
Mice, SCID | 2 | 2006 | 2626 | 0.020 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2014 | 445 | 0.020 |
Why?
|
Massachusetts | 2 | 2020 | 8833 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13381 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 1989 | 153 | 0.020 |
Why?
|
Osseointegration | 1 | 1991 | 274 | 0.020 |
Why?
|
Meningococcal Infections | 1 | 1989 | 77 | 0.020 |
Why?
|
Polymyxin B | 1 | 1988 | 44 | 0.020 |
Why?
|
Serum Amyloid P-Component | 1 | 1988 | 46 | 0.020 |
Why?
|
Pancreatic Elastase | 1 | 1988 | 127 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 80647 | 0.020 |
Why?
|
Plasmapheresis | 1 | 1989 | 206 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8527 | 0.020 |
Why?
|
Pseudomonas | 1 | 1988 | 124 | 0.020 |
Why?
|
Methotrexate | 1 | 1995 | 1719 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1988 | 321 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1998 | 3208 | 0.020 |
Why?
|
Lyme Disease | 1 | 1994 | 631 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6345 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2014 | 1784 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1989 | 755 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1996 | 6228 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12059 | 0.020 |
Why?
|
Spherocytosis, Hereditary | 1 | 2007 | 83 | 0.020 |
Why?
|
Blood Transfusion | 2 | 1993 | 1301 | 0.020 |
Why?
|
Muramidase | 1 | 1987 | 169 | 0.020 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1989 | 361 | 0.020 |
Why?
|
Heart | 1 | 2020 | 4404 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3883 | 0.020 |
Why?
|
Zoonoses | 1 | 2008 | 179 | 0.020 |
Why?
|
Quinolinium Compounds | 1 | 2006 | 10 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 2 | 1987 | 662 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1995 | 1886 | 0.020 |
Why?
|
Hematologic Tests | 1 | 2007 | 239 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6131 | 0.020 |
Why?
|
Superoxides | 1 | 1987 | 387 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4281 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 2005 | 151 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 1984 | 1560 | 0.020 |
Why?
|
Vascular Resistance | 1 | 1989 | 930 | 0.020 |
Why?
|
Biopsy | 1 | 1997 | 6766 | 0.020 |
Why?
|
Splenectomy | 1 | 2007 | 391 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1995 | 17635 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 1994 | 1230 | 0.020 |
Why?
|
Benzoxazoles | 1 | 2006 | 90 | 0.020 |
Why?
|
Spleen | 2 | 2004 | 2295 | 0.020 |
Why?
|
Recurrence | 2 | 2008 | 8466 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8710 | 0.020 |
Why?
|
Complement C3b | 1 | 1984 | 97 | 0.010 |
Why?
|
Receptors, Transferrin | 1 | 2006 | 291 | 0.010 |
Why?
|
Biological Assay | 1 | 1987 | 626 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1971 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6484 | 0.010 |
Why?
|
Lymphatic Diseases | 1 | 2006 | 320 | 0.010 |
Why?
|
Kinetics | 4 | 1994 | 6374 | 0.010 |
Why?
|
Lymphocytes | 1 | 1991 | 2612 | 0.010 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1983 | 41 | 0.010 |
Why?
|
Parasitemia | 1 | 2004 | 165 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6815 | 0.010 |
Why?
|
Zymosan | 1 | 1983 | 134 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 2112 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.010 |
Why?
|
Complement Pathway, Classical | 1 | 1982 | 91 | 0.010 |
Why?
|
Automation | 1 | 2005 | 586 | 0.010 |
Why?
|
Hemophilia B | 1 | 1983 | 84 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1914 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2008 | 858 | 0.010 |
Why?
|
Elapid Venoms | 2 | 1980 | 40 | 0.010 |
Why?
|
Critical Care | 1 | 1995 | 2697 | 0.010 |
Why?
|
Magnesium Chloride | 1 | 1981 | 30 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1993 | 3032 | 0.010 |
Why?
|
Diagnosis, Differential | 3 | 2007 | 12973 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1981 | 167 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2005 | 570 | 0.010 |
Why?
|
Lymphokines | 1 | 1984 | 927 | 0.010 |
Why?
|
Phagocytosis | 1 | 1987 | 1528 | 0.010 |
Why?
|
Bacteroides | 1 | 1981 | 165 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10090 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4369 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1993 | 4431 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1995 | 3165 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15633 | 0.010 |
Why?
|
Body Temperature | 2 | 1994 | 781 | 0.010 |
Why?
|
Hemophilia A | 1 | 1983 | 360 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 2414 | 0.010 |
Why?
|
Papillomaviridae | 1 | 2005 | 1119 | 0.010 |
Why?
|
Dyspnea | 1 | 2007 | 1347 | 0.010 |
Why?
|
Complement Activating Enzymes | 1 | 1978 | 22 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1995 | 4251 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1987 | 1457 | 0.010 |
Why?
|
Sialic Acids | 1 | 1979 | 123 | 0.010 |
Why?
|
Time Factors | 5 | 1992 | 39969 | 0.010 |
Why?
|
Neuraminidase | 1 | 1979 | 196 | 0.010 |
Why?
|
Tritium | 2 | 1989 | 708 | 0.010 |
Why?
|
Syndrome | 2 | 1993 | 3267 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1496 | 0.010 |
Why?
|
Mitogens | 1 | 1998 | 230 | 0.010 |
Why?
|
Magnesium | 1 | 1981 | 804 | 0.010 |
Why?
|
Incidence | 2 | 1994 | 21355 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6312 | 0.010 |
Why?
|
Energy Metabolism | 1 | 1988 | 2882 | 0.010 |
Why?
|
Esterases | 1 | 1976 | 98 | 0.010 |
Why?
|
Melanoma | 1 | 1995 | 5709 | 0.010 |
Why?
|
Hemolysis | 1 | 1979 | 415 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1990 | 7593 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1978 | 1310 | 0.010 |
Why?
|
Abscess | 1 | 1980 | 606 | 0.010 |
Why?
|
Treponema pallidum | 1 | 1976 | 47 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6965 | 0.010 |
Why?
|
Proteins | 1 | 1991 | 6032 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5870 | 0.010 |
Why?
|
Antigens, CD | 1 | 2006 | 4001 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 74213 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1976 | 641 | 0.010 |
Why?
|
Candida albicans | 1 | 1978 | 372 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23996 | 0.010 |
Why?
|
Menstruation | 1 | 1976 | 307 | 0.010 |
Why?
|
Erythema | 1 | 1976 | 262 | 0.010 |
Why?
|
Digestive System | 1 | 1995 | 244 | 0.010 |
Why?
|
Adhesiveness | 1 | 1994 | 52 | 0.010 |
Why?
|
Erythrocyte Deformability | 1 | 1994 | 55 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2005 | 5247 | 0.010 |
Why?
|
Quinine | 1 | 1994 | 51 | 0.010 |
Why?
|
Neoplasms | 2 | 2014 | 22173 | 0.010 |
Why?
|
Clindamycin | 1 | 1994 | 139 | 0.010 |
Why?
|
Permeability | 1 | 1995 | 723 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39106 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2005 | 1613 | 0.010 |
Why?
|
Receptors, Complement | 1 | 1994 | 253 | 0.010 |
Why?
|
Inflammation | 1 | 1993 | 10774 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3093 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 64685 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1994 | 367 | 0.010 |
Why?
|
Umbilical Veins | 1 | 1993 | 426 | 0.010 |
Why?
|
Acute Disease | 2 | 1994 | 7237 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1992 | 306 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1993 | 422 | 0.010 |
Why?
|
Body Surface Area | 1 | 1992 | 197 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 262 | 0.010 |
Why?
|
Burn Units | 1 | 1992 | 143 | 0.010 |
Why?
|
Immune Sera | 1 | 1992 | 606 | 0.010 |
Why?
|
Complement Membrane Attack Complex | 1 | 1991 | 105 | 0.010 |
Why?
|
Skin Diseases | 1 | 1980 | 1094 | 0.010 |
Why?
|
Pneumonia | 1 | 1983 | 2143 | 0.010 |
Why?
|
Mucus | 1 | 1993 | 341 | 0.010 |
Why?
|
Teichoic Acids | 1 | 1991 | 70 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1983 | 2244 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2217 | 0.010 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 221 | 0.010 |
Why?
|
Liver | 2 | 1994 | 7528 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 1992 | 249 | 0.010 |
Why?
|
Child | 3 | 1995 | 80158 | 0.010 |
Why?
|
Surface Tension | 1 | 1989 | 43 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22176 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1995 | 1189 | 0.010 |
Why?
|
Autoantigens | 1 | 1994 | 891 | 0.010 |
Why?
|
Epinephrine | 1 | 1993 | 792 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1990 | 817 | 0.010 |
Why?
|
Rectum | 1 | 1994 | 892 | 0.010 |
Why?
|
Organ Specificity | 1 | 1994 | 1968 | 0.010 |
Why?
|
Sex Factors | 1 | 1983 | 10554 | 0.010 |
Why?
|
Cell Membrane | 1 | 1979 | 3687 | 0.010 |
Why?
|
Glycoproteins | 1 | 1976 | 2203 | 0.010 |
Why?
|
Neisseria meningitidis | 1 | 1989 | 108 | 0.010 |
Why?
|
Pulse | 1 | 1988 | 217 | 0.000 |
Why?
|
Headache | 1 | 1976 | 1256 | 0.000 |
Why?
|
Brain | 1 | 2015 | 27121 | 0.000 |
Why?
|
Hospitals, General | 1 | 1992 | 798 | 0.000 |
Why?
|
alpha 1-Antitrypsin | 1 | 1988 | 167 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2503 | 0.000 |
Why?
|
Carbon Radioisotopes | 1 | 1988 | 561 | 0.000 |
Why?
|
Fluid Therapy | 1 | 1991 | 579 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2005 | 20100 | 0.000 |
Why?
|
Administration, Oral | 1 | 1995 | 4021 | 0.000 |
Why?
|
Necrosis | 1 | 1991 | 1611 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1989 | 685 | 0.000 |
Why?
|
Immunotherapy | 2 | 1993 | 4652 | 0.000 |
Why?
|
Glucagon | 1 | 1988 | 532 | 0.000 |
Why?
|
Bacteremia | 1 | 1993 | 980 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1989 | 1031 | 0.000 |
Why?
|
Body Weight | 1 | 1976 | 4618 | 0.000 |
Why?
|
Cell Communication | 1 | 1993 | 1657 | 0.000 |
Why?
|
Liposomes | 1 | 1989 | 783 | 0.000 |
Why?
|
United States | 1 | 2014 | 72340 | 0.000 |
Why?
|
Reference Values | 1 | 1992 | 4920 | 0.000 |
Why?
|
Carbon Dioxide | 1 | 1988 | 1147 | 0.000 |
Why?
|
Amyloid | 1 | 1988 | 841 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1994 | 2630 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8181 | 0.000 |
Why?
|
Kidney | 1 | 1978 | 7048 | 0.000 |
Why?
|
Liver Diseases | 1 | 1991 | 1297 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1988 | 2231 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13446 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1988 | 1866 | 0.000 |
Why?
|
Respiration | 1 | 1988 | 1656 | 0.000 |
Why?
|
Peptides | 1 | 1994 | 4358 | 0.000 |
Why?
|
Swine | 1 | 1991 | 5915 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1989 | 1819 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1991 | 5485 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1976 | 8002 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1980 | 397 | 0.000 |
Why?
|
Cecum | 1 | 1980 | 233 | 0.000 |
Why?
|
Prospective Studies | 2 | 1995 | 54423 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1985 | 2329 | 0.000 |
Why?
|
Survival Rate | 1 | 1992 | 12723 | 0.000 |
Why?
|
Glucose | 1 | 1988 | 4347 | 0.000 |
Why?
|
Methyltestosterone | 1 | 1976 | 19 | 0.000 |
Why?
|
Complement Inactivator Proteins | 1 | 1976 | 74 | 0.000 |
Why?
|
DNA | 1 | 1989 | 7213 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1992 | 15843 | 0.000 |
Why?
|
Insulin | 1 | 1988 | 6597 | 0.000 |
Why?
|
Mice, Nude | 1 | 1980 | 3614 | 0.000 |
Why?
|
Tranexamic Acid | 1 | 1976 | 176 | 0.000 |
Why?
|
Progesterone | 1 | 1976 | 742 | 0.000 |
Why?
|
Prognosis | 1 | 1992 | 29629 | 0.000 |
Why?
|
Child, Preschool | 1 | 1992 | 42232 | 0.000 |
Why?
|
Pedigree | 1 | 1976 | 4542 | 0.000 |
Why?
|
Intubation, Intratracheal | 1 | 1976 | 1333 | 0.000 |
Why?
|
Pregnancy | 1 | 1976 | 29890 | 0.000 |
Why?
|